Recent study evaluated hemolysis in patients supported with the Impella 5.5 percutaneous left ventricular assist device in a ...

March 27, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, the global leader in heart recovery, will feature the latest evidence demonstrating the survival benefit of Impella® heart pump ...

Select patients with heart failure fitted with an implantable left ventricular assist device ... a transcatheter approach was used to implant the Impella 5.5 device (Abiomed) into the left ventricle.